Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Creagh

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
The Journal of Urology|April 1, 1993
Pharmacological manipulation of acute cyclosporin ischemic renal injury with trimetazidineT Creagh, D Lanigan, J Dolan, et al.
AIDS (London, England)|July 1, 1992
Natural history of advanced HIV disease in patients treated with zidovudine. The Zidovudine Epidemiology Study GroupR D Moore, J Keruly, D D Richman, et al.
Urological Research|October 24, 2003
Neutrophil bactericidal function is defective in patients with recurrent urinary tract infectionsC Condron, D Toomey, R G Casey, et al.
Chemotherapy|January 1, 1980
Toxicity and tolerance of 9-(2-hydroxyethoxymethyl)guanineK S Morgan, A H Wander, H E Kaufman, et al.
Journal of Clinical Pathology|January 1, 1995
Pathologist variation in reporting cervical borderline epithelial abnormalities and cervical intraepithelial neoplasiaT Creagh, J E Bridger, E Kupek, et al.
JAMA|November 25, 1988
Survival experience among patients with AIDS receiving zidovudine. Follow-up of patients in a compassionate plea programT Creagh-Kirk, P Doi, E Andrews, et al.
Archives of Internal Medicine|May 1, 1991
Long-term safety and efficacy of zidovudine in patients with advanced human immunodeficiency virus disease. Zidovudine Epidemiology Study GroupR D Moore, T Creagh-Kirk, J Keruly, et al.
Journal of Pharmaceutical Sciences|November 23, 2006
Lyophilization cycle development for a high-concentration monoclonal antibody formulation lacking a crystalline bulking agentJames D Colandene, Linda M Maldonado, Alma T Creagh, et al.
JAMA|November 20, 1991
Racial and ethnic differences in outcome in zidovudine-treated patients with advanced HIV disease. Zidovudine Epidemiology Study GroupP J Easterbrook, J C Keruly, T Creagh-Kirk, et al.
British Medical Journal (Clinical Research Ed.)|October 25, 1986
When things go wrongB Crossley, M Gillett, T Creagh, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
The Journal of Urology|April 1, 1993
Pharmacological manipulation of acute cyclosporin ischemic renal injury with trimetazidineT Creagh, D Lanigan, J Dolan, et al.
AIDS (London, England)|July 1, 1992
Natural history of advanced HIV disease in patients treated with zidovudine. The Zidovudine Epidemiology Study GroupR D Moore, J Keruly, D D Richman, et al.
Urological Research|October 24, 2003
Neutrophil bactericidal function is defective in patients with recurrent urinary tract infectionsC Condron, D Toomey, R G Casey, et al.
Chemotherapy|January 1, 1980
Toxicity and tolerance of 9-(2-hydroxyethoxymethyl)guanineK S Morgan, A H Wander, H E Kaufman, et al.
Journal of Clinical Pathology|January 1, 1995
Pathologist variation in reporting cervical borderline epithelial abnormalities and cervical intraepithelial neoplasiaT Creagh, J E Bridger, E Kupek, et al.
JAMA|November 25, 1988
Survival experience among patients with AIDS receiving zidovudine. Follow-up of patients in a compassionate plea programT Creagh-Kirk, P Doi, E Andrews, et al.
Archives of Internal Medicine|May 1, 1991
Long-term safety and efficacy of zidovudine in patients with advanced human immunodeficiency virus disease. Zidovudine Epidemiology Study GroupR D Moore, T Creagh-Kirk, J Keruly, et al.
Journal of Pharmaceutical Sciences|November 23, 2006
Lyophilization cycle development for a high-concentration monoclonal antibody formulation lacking a crystalline bulking agentJames D Colandene, Linda M Maldonado, Alma T Creagh, et al.
JAMA|November 20, 1991
Racial and ethnic differences in outcome in zidovudine-treated patients with advanced HIV disease. Zidovudine Epidemiology Study GroupP J Easterbrook, J C Keruly, T Creagh-Kirk, et al.
British Medical Journal (Clinical Research Ed.)|October 25, 1986
When things go wrongB Crossley, M Gillett, T Creagh, et al.
Pageof 4